1. Home
  2. BNZI vs RNAZ Comparison

BNZI vs RNAZ Comparison

Compare BNZI & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$3.25

Market Cap

5.7M

Sector

N/A

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$8.73

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
RNAZ
Founded
2016
2016
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BNZI
RNAZ
Price
$3.25
$8.73
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
319.0K
28.4K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.28
N/A
Revenue Next Year
$0.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$3.82
52 Week High
$8.10
$20.99

Technical Indicators

Market Signals
Indicator
BNZI
RNAZ
Relative Strength Index (RSI) 51.90 64.77
Support Level $2.80 $8.38
Resistance Level $3.99 $9.68
Average True Range (ATR) 0.25 1.17
MACD 0.00 0.45
Stochastic Oscillator 73.23 74.02

Price Performance

Historical Comparison
BNZI
RNAZ

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: